Catto JW - Search Results

1

Identification of differentially expressed long noncoding RNAs in bladder cancer.

Peter S, Borkowska E, Drayton RM, Rakhit CP, Noon A, Chen W, Catto JW. Peter S, et al. Among authors: catto jw. Clin Cancer Res. 2014 Oct 15;20(20):5311-21. doi: 10.1158/1078-0432.CCR-14-0706. Epub 2014 Aug 27. Clin Cancer Res. 2014. PMID: 25165097

2

Artificial intelligence in predicting bladder cancer outcome: a comparison of neuro-fuzzy modeling and artificial neural networks.

Catto JW, Linkens DA, Abbod MF, Chen M, Burton JL, Feeley KM, Hamdy FC. Catto JW, et al. Clin Cancer Res. 2003 Sep 15;9(11):4172-7. Clin Cancer Res. 2003. PMID: 14519642

3

Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.

Catto JW, Azzouzi AR, Rehman I, Feeley KM, Cross SS, Amira N, Fromont G, Sibony M, Cussenot O, Meuth M, Hamdy FC. Catto JW, et al. J Clin Oncol. 2005 May 1;23(13):2903-10. doi: 10.1200/JCO.2005.03.163. Epub 2005 Mar 7. J Clin Oncol. 2005. PMID: 15753461

4

Neuro-fuzzy modeling: an accurate and interpretable method for predicting bladder cancer progression.

Catto JW, Abbod MF, Linkens DA, Hamdy FC. Catto JW, et al. J Urol. 2006 Feb;175(2):474-9. doi: 10.1016/S0022-5347(05)00246-6. J Urol. 2006. PMID: 16406976

5

Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage.

Rouprêt M, Hupertan V, Yates DR, Catto JW, Rehman I, Meuth M, Ricci S, Lacave R, Cancel-Tassin G, de la Taille A, Rozet F, Cathelineau X, Vallancien G, Hamdy FC, Cussenot O. Rouprêt M, et al. Among authors: catto jw. Clin Cancer Res. 2007 Mar 15;13(6):1720-5. doi: 10.1158/1078-0432.CCR-06-2467. Clin Cancer Res. 2007. PMID: 17363525

6

Promoter hypermethylation identifies progression risk in bladder cancer.

Yates DR, Rehman I, Abbod MF, Meuth M, Cross SS, Linkens DA, Hamdy FC, Catto JW. Yates DR, et al. Among authors: catto jw. Clin Cancer Res. 2007 Apr 1;13(7):2046-53. doi: 10.1158/1078-0432.CCR-06-2476. Clin Cancer Res. 2007. PMID: 17404085 Free article.

7

Neurofuzzy modeling to determine recurrence risk following radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.

Catto JW, Abbod MF, Linkens DA, Larré S, Rosario DJ, Hamdy FC. Catto JW, et al. Clin Cancer Res. 2009 May 1;15(9):3150-5. doi: 10.1158/1078-0432.CCR-08-1960. Epub 2009 Mar 31. Clin Cancer Res. 2009. PMID: 19336522 Free article.

8

Distinct microRNA alterations characterize high- and low-grade bladder cancer.

Catto JW, Miah S, Owen HC, Bryant H, Myers K, Dudziec E, Larré S, Milo M, Rehman I, Rosario DJ, Di Martino E, Knowles MA, Meuth M, Harris AL, Hamdy FC. Catto JW, et al. Cancer Res. 2009 Nov 1;69(21):8472-81. doi: 10.1158/0008-5472.CAN-09-0744. Epub 2009 Oct 20. Cancer Res. 2009. PMID: 19843843 Free PMC article.

9

The application of artificial intelligence to microarray data: identification of a novel gene signature to identify bladder cancer progression.

Catto JW, Abbod MF, Wild PJ, Linkens DA, Pilarsky C, Rehman I, Rosario DJ, Denzinger S, Burger M, Stoehr R, Knuechel R, Hartmann A, Hamdy FC. Catto JW, et al. Eur Urol. 2010 Mar;57(3):398-406. doi: 10.1016/j.eururo.2009.10.029. Epub 2009 Nov 6. Eur Urol. 2010. PMID: 19913990 Free article.

10

Epigenetic regulation of microRNA expression in cancer.

Choudhry H, Catto JW. Choudhry H, et al. Among authors: catto jw. Methods Mol Biol. 2011;676:165-84. doi: 10.1007/978-1-60761-863-8_12. Methods Mol Biol. 2011. PMID: 20931397

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

274 results

Search Page